Invested in Apini Therapeutics, developer of novel small molecule treatments for chronic inflammatory bowel diseases.
Apini Therapeutics is a fully virtual biotech company focused on advancing novel treatments for inflammatory diseases without inducing immune suppression
Apini Therapeutics is a fully virtual biotech company focused on advancing novel treatments for inflammatory diseases without inducing immune suppression. It combines scientific leadership with experienced drug discovery execution.